Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |